Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.

Computational and mathematical methods in medicine - 1 Jan 2020

Lin Jiaqiong, Lin Yan, Huang Zena, Li Xiaoyong

Abstract excerpt

BACKGROUND: Immunotherapy offers a novel approach for the treatment of cutaneous melanoma, but the clinical efficiency varies for individual patients. In consideration of the high cost and adverse effects of immunotherapy, it is essential to explore the predictive biomarkers of outcomes. Recently, the tumor mutation burden (TMB) has been proposed as a predictive prognosticator of the immune response. METHOD:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Computational Biology
Share to Immunotherapy
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocytes, Tumor-Infiltrating

Share to Melanoma

Share to Models, Immunological

Share to Proportional Hazards Models

Share to Skin Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 33273963
DOI: 10.1155/2020/8836493
PMCID: PMC7683164

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.PMID 33273963Read ↗

Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous MelanomaSemantic proximity Read ↗

Gene expression and immune infiltration in melanoma patients with different mutation burden.Semantic proximity Read ↗

Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma.Semantic proximity Read ↗

Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics AnalysisSemantic proximity Read ↗

Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.Semantic proximity Read ↗

The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesSemantic proximity Read ↗

Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy PredictionSemantic proximity Read ↗

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma.Semantic proximity Read ↗

Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.Semantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in MelanomaSemantic proximity Read ↗

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden.Semantic proximity Read ↗

Identification and validation of three risk models in skin melanoma based on bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.